Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-{[2-Oxo-2-(1-piperidinyl)ethyl]sulfanyl}-6-(trifluoromethyl)-4(1H)-pyrimidinone
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
2-{[2-Oxo-2-(1-piperidinyl)ethyl]sulfanyl}-6-(trifluoromethyl)-4(1H)-pyrimidinone is a synthetic organic compound with the molecular formula C12H14F3N3O2S and a molecular weight of 321.32 g/mol. It is classified as a pharmaceutical compound, suggesting its potential relevance in drug discovery or development. However, specific information regarding its mechanism of action, primary indication, or development status is not publicly available, indicating it may be a research compound or an intermediate without established clinical applications.
- Other names
- 2-((2-Oxo-2-(1-piperidinyl)ethyl)sulfanyl)-6-(trifluoromethyl)-4(1H)-pyrimidinone2-((2-oxo-2-(piperidin-1-yl)ethyl)sulfanyl)-6-(trifluoromethyl)-1,4-dihydropyrimidin-4-one2-{[2-oxo-2-(piperidin-1-yl)ethyl]sulfanyl}-6-(trifluoromethyl)-1,4-dihydropyrimidin-4-oneRefChem:4478602-(2-oxo-2-piperidin-1-ylethyl)sulfanyl-4-(trifluoromethyl)-1H-pyrimidin-6-one
02
Targets
FABP4 (Fatty acid-binding protein 4)
Beyond the preview
Go deeper on 2-{[2-Oxo-2-(1-piperidinyl)ethyl]sulfanyl}-6-(trifluoromethyl)-4(1H)-pyrimidinone.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-{[2-Oxo-2-(1-piperidinyl)ethyl]sulfanyl}-6-(trifluoromethyl)-4(1H)-pyrimidinone.